Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Nature Medicine|February 1, 2022
Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trialJeffrey S Miller, Zachary B Davis, Erika Helgeson, et al.The Lancet. Microbe|March 13, 2025
Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control studyMosoka P Fallah, Collin Van Ryn, J Soka Moses, et al.Translational Vision Science & Technology|February 1, 2021
Efficacy and Safety Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease: 12-Month Results From the PREVAIL VII StudyAllen O Eghrari, Jessica G Shantha, Robin D Ross, et al.Immunity, Inflammation and Disease|March 12, 2026
Investigating the Impact of Host Genetics on the Risk of Disease Progression in Individuals With InfluenzaSara Bohnstedt Mørup, Maja Milojevic, Seyed Mahmood Taghavi Shahri, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 14, 2019
Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid TissuesMeghan Rothenberger, Krystelle Nganou-Makamdop, Cissy Kityo, et al.The Journal of Infectious Diseases|March 11, 2022
Paradoxically Greater Persistence of HIV RNA-Positive Cells in Lymphoid Tissue When ART Is Initiated in the Earliest Stage of InfectionEugène Kroon, Suthat Chottanapund, Supranee Buranapraditkun, et al.The Lancet. Global Health|June 22, 2023
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort studyMosoka P Fallah, Cavan Reilly, Collin Van Ryn, et al.Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruptionMeghan K Rothenberger, Brandon F Keele, Stephen W Wietgrefe, et al.Proceedings of the National Academy of Sciences of the United States of America|February 3, 2022
Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccination in exposed and potentially exposed persons in the Democratic Republic of the CongoNicole A Hoff, Anna Bratcher, J Daniel Kelly, et al.JAMA Network Open|January 5, 2021
Characterization of Ebola Virus-Associated Eye DiseaseAllen O Eghrari, Rachel J Bishop, Robin D Ross, et al.Pageof 11